Influenza A Virus H1N1 Subtype Infections-Pipeline Review H2 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H1N1 Subtype Infections-Pipeline Review, H2 2017, provides an overview of the Influenza A Virus, H1N1 Subtype Infections (Infectious Disease) pipeline landscape.
(EMAILWIRE.COM, September 29, 2017 ) H1N1 Infection also called as swine flu is a new kind of flu in humans. It's caused by a contagious virus. H1N1 flu infects the breathing tubes in nose, throat, and lungs. The disease is contagious. When people who have it cough or sneeze, they spray tiny drops of the virus into the air. Signs and symptoms include cough, fever, sore throat, stuffy or runny nose, body aches, headache and fatigue. Treatment includes medication (antiviral drugs).
Report Highlights
Publisher's Pharmaceutical and Healthcare latest pipeline guide Influenza A Virus, H1N1 Subtype Infections-Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Influenza A Virus, H1N1 Subtype Infections (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Get Sample Copy of Report@ http://www.reportsweb.com/inquiry&RW00011060438/sample
The Influenza A Virus, H1N1 Subtype Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenza A Virus, H1N1 Subtype Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 2, 10, 7, 7, 1, 47, 6 and 1 respectively. Similarly, the Universities portfolio in Phase III, Phase II, Preclinical and Discovery stages comprises 2, 1, 11 and 3 molecules, respectively.
Influenza A Virus, H1N1 Subtype Infections (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Get Discount@ http://www.reportsweb.com/inquiry&RW00011060438/discount
Table of Contents
Table of Contents 2
Introduction 5
Influenza A Virus, H1N1 Subtype Infections-Overview 6
Influenza A Virus, H1N1 Subtype Infections-Therapeutics Development 7
Influenza A Virus, H1N1 Subtype Infections-Therapeutics Assessment 21
Influenza A Virus, H1N1 Subtype Infections-Companies Involved in Therapeutics Development 29
Influenza A Virus, H1N1 Subtype Infections-Drug Profiles 50
Influenza A Virus, H1N1 Subtype Infections-Dormant Projects 182
Influenza A Virus, H1N1 Subtype Infections-Discontinued Products 185
Influenza A Virus, H1N1 Subtype Infections-Product Development Milestones 186
Appendix 198
List of Figures
Number of Products under Development for Influenza A Virus, H1N1 Subtype Infections, H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products under Development by Universities/Institutes, H2 2017
Number of Products by Top 10 Targets, H2 2017
Number of Products by Stage and Top 10 Targets, H2 2017
Number of Products by Top 10 Mechanism of Actions, H2 2017
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2017
Number of Products by Top 10 Routes of Administration, H2 2017
Number of Products by Stage and Top 10 Routes of Administration, H2 2017
Number of Products by Top 10 Molecule Types, H2 2017
Number of Products by Stage and Top 10 Molecule Types, H2 2017
Buy This Report@ http://www.reportsweb.com/buy&RW00011060438/buy/2000
Report Highlights
Publisher's Pharmaceutical and Healthcare latest pipeline guide Influenza A Virus, H1N1 Subtype Infections-Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Influenza A Virus, H1N1 Subtype Infections (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Get Sample Copy of Report@ http://www.reportsweb.com/inquiry&RW00011060438/sample
The Influenza A Virus, H1N1 Subtype Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenza A Virus, H1N1 Subtype Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 2, 10, 7, 7, 1, 47, 6 and 1 respectively. Similarly, the Universities portfolio in Phase III, Phase II, Preclinical and Discovery stages comprises 2, 1, 11 and 3 molecules, respectively.
Influenza A Virus, H1N1 Subtype Infections (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Get Discount@ http://www.reportsweb.com/inquiry&RW00011060438/discount
Table of Contents
Table of Contents 2
Introduction 5
Influenza A Virus, H1N1 Subtype Infections-Overview 6
Influenza A Virus, H1N1 Subtype Infections-Therapeutics Development 7
Influenza A Virus, H1N1 Subtype Infections-Therapeutics Assessment 21
Influenza A Virus, H1N1 Subtype Infections-Companies Involved in Therapeutics Development 29
Influenza A Virus, H1N1 Subtype Infections-Drug Profiles 50
Influenza A Virus, H1N1 Subtype Infections-Dormant Projects 182
Influenza A Virus, H1N1 Subtype Infections-Discontinued Products 185
Influenza A Virus, H1N1 Subtype Infections-Product Development Milestones 186
Appendix 198
List of Figures
Number of Products under Development for Influenza A Virus, H1N1 Subtype Infections, H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products under Development by Universities/Institutes, H2 2017
Number of Products by Top 10 Targets, H2 2017
Number of Products by Stage and Top 10 Targets, H2 2017
Number of Products by Top 10 Mechanism of Actions, H2 2017
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2017
Number of Products by Top 10 Routes of Administration, H2 2017
Number of Products by Stage and Top 10 Routes of Administration, H2 2017
Number of Products by Top 10 Molecule Types, H2 2017
Number of Products by Stage and Top 10 Molecule Types, H2 2017
Buy This Report@ http://www.reportsweb.com/buy&RW00011060438/buy/2000
Contact Information:
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results